Atlas Trials

European Study of 3APS in Mild to Moderate Alzheimer's Disease Patients

Clinical trial NCT00217763 · UNKNOWN

Trial details

NCT number
NCT00217763
Sponsor
Bellus Health Inc. - a GSK company
Status
UNKNOWN
Phase
Phase 3
Study type
INTERVENTIONAL
Alzheimer's Disease
Start date
2005-09-01
Enrollment
930

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.